Black has held numerous leadership roles within the medtech industry. He has over 20 years of executive management experience in the industry and has led early-stage medical device companies through commercialization and successful exit with strategic partners. Most recently, he was president of Bedrock Medtech Consulting. He has also served as CEO of Advanced Circulatory Systems and VP of global customer experience at Zoll Medical.
“Mike is a great fit for helping our start-up company take on one of medicine’s most intractable problems – improving the efficacy of CPR. I genuinely believe our chances for success go up significantly having Mike in this important role,” Founder, President and CEO Dr. Norman Paradis said in a news release.
The Putney, Vermont-based early-stage medtech company is developing the next generation of technology for cardiopulmonary resuscitation. CPR Therapeutics is funded by the National Institutes of Health and the National Science Foundation.
“I’m looking forward to advising the CPR Therapeutics team on the development of this important suite of medical technologies. I have a long-term commitment to improving the outcome of patients suffering cardiac arrest. CPR-T’s approach is a major opportunity to advance care and have a meaningful impact on one of the leading killers worldwide,” Black said.
